RSI Oversold Bounce Stocks — Performance View · Healthcare
143 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Performance columns. Filtered to Healthcare. Data as of close · Checked
Filters2
1–100 of 143
Page of 2
| KLAC | KLA Corporation | +1.88% | -26.57% | -20.70% | -10.94% | +25.25% | +25.07% | 5.3% | 4.5% | 1.55 | 401K | 152.02 | -3.68% | 621K |
| INSM | Insmed Incorporated | +17.11% | -1.64% | +10.75% | -21.89% | -43.74% | -37.19% | 5.1% | 3.8% | 0.83 | 183K | 109.33 | -2.90% | 151K |
| MKSI | MKS Instruments | -2.94% | -29.58% | -38.76% | -32.59% | +40.95% | +22.82% | 4.4% | 4.8% | 1.13 | 86K | 196.42 | -2.65% | 97K |
| MDGL | Madrigal Pharmaceuticals, Inc. | -1.50% | -13.61% | -15.12% | -16.92% | +0.74% | -26.16% | 3.9% | 3.9% | 1.65 | 20K | 430.84 | +0.16% | 34K |
| ONTO | Onto Innovation | -5.91% | -41.62% | -32.65% | -36.12% | +39.52% | +21.16% | 6.3% | 5.7% | 0.66 | 67K | 191.27 | -5.02% | 44K |
| BKD | Brookdale Senior Living Inc. | +7.07% | -3.78% | -26.56% | -25.46% | +12.91% | -3.11% | 13.7% | 8.1% | 1.26 | 366K | 10.45 | +0.63% | 461K |
| TMDX | Transmedics Group, Inc. | -5.70% | -16.66% | -11.28% | -31.38% | -50.96% | -45.32% | 4.1% | 4.6% | 1.01 | 44K | 66.54 | +1.05% | 44K |
| RCUS | Arcus Biosciences, Inc. | +0.45% | -26.98% | -38.09% | -31.53% | -11.61% | -25.09% | 5.5% | 7.3% | 0.80 | 118K | 17.85 | -1.82% | 95K |
| URGN | Urogen Pharma Ltd. | +1.03% | -16.92% | -13.76% | +47.74% | +73.02% | +46.80% | 5.3% | 6.0% | 2.47 | 53K | 34.38 | +5.07% | 130K |
| SNDA | Sonida Senior Living, Inc. | +1.06% | -10.06% | -12.06% | -9.47% | +33.18% | +4.16% | 5.0% | 4.4% | 0.99 | 28K | 33.90 | -1.15% | 28K |
| NKTR | Nektar Therapeutics | -1.33% | -15.35% | -49.17% | -57.45% | -41.16% | -12.53% | 4.1% | 5.5% | 0.58 | 53K | 36.96 | -4.93% | 30K |
| RAPP | Rapport Therapeutics, Inc. | -0.83% | -21.96% | -40.54% | -29.35% | -6.41% | -17.34% | 13.2% | 12.2% | 1.32 | 43K | 25.10 | +0.32% | 57K |
| SNDX | Syndax Pharmaceuticals Inc | -1.06% | -25.74% | -31.48% | -34.52% | -2.54% | -37.82% | 9.2% | 7.0% | 1.78 | 122K | 13.07 | -4.11% | 217K |
| ATEC | Alphatec Holdings, Inc. | -32.91% | -27.19% | -29.37% | -29.24% | -63.23% | -65.27% | 20.7% | 9.0% | 4.84 | 241K | 7.31 | +3.54% | 1.2M |
| IRMD | Iradimed Corp | -6.10% | -7.05% | -14.80% | -6.42% | +3.63% | -18.28% | 4.0% | 3.7% | 3.26 | 5K | 79.41 | +3.50% | 18K |
| ORIC | Oric Pharmaceuticals, Inc. | +1.28% | -25.66% | -32.86% | -5.62% | -32.01% | +10.81% | 8.4% | 9.0% | 1.08 | 101K | 9.07 | -1.95% | 109K |
| INMD | Inmode Ltd. | -0.29% | -2.84% | -10.93% | -4.30% | -6.87% | -6.84% | 2.1% | 1.4% | 1.50 | 47K | 13.69 | +3.56% | 70K |
| LXRX | Lexicon Pharmaceuticals, Inc. | +0.00% | -20.88% | -42.40% | -9.72% | +7.46% | +26.32% | 5.1% | 4.9% | 0.73 | 213K | 1.44 | +0.70% | 155K |
| CADL | Candel Therapeutics, Inc. | +4.11% | -20.37% | -22.65% | +7.56% | +50.19% | +43.67% | 5.7% | 5.7% | 1.16 | 59K | 8.11 | -2.70% | 69K |
| AVR | Anteris Technologies Global Corp. | -0.35% | -25.06% | -30.23% | -5.95% | +32.64% | +15.40% | 8.4% | 5.5% | 3.81 | 54K | 5.77 | -8.63% | 204K |
| GYRE | GYRE THERAPEUTICS, INC. | -22.22% | -33.64% | -23.48% | -40.27% | -38.07% | -32.88% | 16.4% | 7.2% | 3.45 | 6K | 4.72 | +3.85% | 20K |
| FTH | Faeth Therapeutics, Inc. | +14.17% | -32.59% | -24.51% | -31.59% | +81.41% | +53.40% | 9.5% | 10.0% | 0.69 | 19K | 19.18 | +2.82% | 13K |
| MDXG | Mimedx Group, Inc. | -15.16% | -28.65% | -23.30% | -9.41% | -55.62% | -51.59% | 8.1% | 5.5% | 1.77 | 95K | 3.27 | -15.81% | 168K |
| ASMB | Assembly Biosciences, Inc. | -0.84% | -13.35% | -26.24% | -30.09% | -35.26% | -42.77% | 4.3% | 4.5% | 1.40 | 16K | 19.50 | -3.37% | 22K |
| ALLO | Allogene Therapeutics, Inc. | -11.48% | -28.48% | -43.16% | -52.00% | -11.11% | -20.88% | 9.1% | 6.5% | 1.20 | 330K | 1.08 | -8.09% | 398K |
| TECX | Tectonic Therapeutic, Inc. | -4.47% | -15.47% | -34.71% | -35.92% | +8.19% | -8.71% | 5.7% | 5.1% | 0.46 | 13K | 19.02 | -3.62% | 6K |
| KYTX | Kyverna Therapeutics, Inc. | -1.14% | -16.80% | -33.16% | -42.16% | -22.85% | -44.56% | 7.9% | 6.1% | 1.40 | 37K | 5.20 | -8.13% | 52K |
| IRD | Opus Genetics, Inc. | +11.90% | -19.06% | -0.13% | -28.97% | +87.63% | +84.83% | 6.5% | 7.2% | 0.50 | 163K | 3.71 | +0.81% | 81K |
| EIKN | Eikon Therapeutics, Inc. | +2.53% | -22.30% | -40.49% | -44.69% | — | -61.65% | 8.3% | 8.5% | 0.78 | 32K | 5.68 | +6.97% | 25K |
| MPLT | Maplight Therapeutics, Inc. | -11.68% | -31.20% | -47.68% | -76.32% | -62.66% | -61.36% | 7.2% | 8.6% | 0.70 | 24K | 6.77 | -10.80% | 17K |
| CGC | Canopy Growth | +2.13% | -22.37% | -27.19% | -38.93% | -44.64% | -40.27% | 4.1% | 5.1% | 0.87 | 85K | 0.68 | +4.07% | 74K |
| BIOA | Bioage Labs, Inc. | +16.87% | -12.08% | -48.04% | -64.93% | -24.51% | -55.98% | 8.1% | 6.5% | 1.31 | 40K | 5.82 | -1.02% | 53K |
| OCGN | Ocugen, Inc. | +1.62% | -28.60% | -44.83% | -55.04% | -52.09% | -45.65% | 7.4% | 6.7% | 0.51 | 260K | 0.73 | +2.84% | 134K |
| CABA | Cabaletta Bio, Inc. | +6.72% | -28.68% | -48.38% | -62.27% | -41.75% | -35.00% | 8.2% | 8.0% | 0.80 | 408K | 1.43 | -5.30% | 327K |
| UTMD | UTAH MEDICAL PRODUCTS INC | -4.17% | -5.33% | -3.04% | +8.76% | +23.28% | +25.38% | 3.7% | 1.6% | 1.04 | 2K | 70.39 | +3.02% | 2K |
| EVMN | Evommune, Inc. | +16.85% | -12.92% | -52.42% | -74.59% | — | -66.80% | 13.6% | 7.9% | 0.62 | 54K | 6.00 | -10.85% | 33K |
| IKT | Inhibikase Therapeutics, Inc. | +1.99% | -23.38% | -36.63% | -20.62% | +6.94% | -25.24% | 6.7% | 6.5% | 0.56 | 51K | 1.54 | -0.65% | 29K |
| UPB | Upstream Bio, Inc. | +22.26% | -33.66% | -50.59% | -62.78% | -87.02% | -87.67% | 9.5% | 9.7% | 1.29 | 66K | 3.35 | -1.76% | 85K |
| SION | Sionna Therapeutics, Inc. | +1.36% | -24.34% | -92.53% | -90.77% | -90.18% | -90.96% | 7.2% | 6.9% | 0.32 | 93K | 3.73 | -3.62% | 29K |
| NNNN | Anbio Biotechnology | -3.38% | -37.06% | -65.09% | -88.02% | -83.57% | -87.72% | 4.7% | 9.7% | 0.47 | 3K | 3.58 | +2.73% | 1K |
| MGNX | MACROGENICS INC | +6.86% | -34.78% | -39.97% | -27.26% | +46.86% | +44.14% | 10.1% | 9.6% | 1.13 | 59K | 2.33 | -3.51% | 67K |
| PRQR | ProQR Therapeutics N.V. | +6.07% | -19.88% | -28.02% | -20.12% | -51.75% | -34.83% | 7.5% | 5.9% | 0.63 | 53K | 1.31 | -5.76% | 34K |
| ZNTL | Zentalis Pharmaceuticals, Inc. | -11.38% | -26.80% | -62.35% | -54.14% | +23.23% | +36.57% | 6.9% | 6.8% | 1.08 | 88K | 1.83 | -6.63% | 94K |
| FHTX | Foghorn Therapeutics Inc. | +3.67% | +4.95% | -56.47% | -54.70% | -50.58% | -60.48% | 5.4% | 5.9% | 1.27 | 36K | 2.12 | +1.92% | 45K |
| AIRS | Airsculpt Technologies, Inc. | +41.53% | -5.65% | -66.40% | -51.59% | -84.26% | -15.66% | 12.0% | 8.8% | 1.23 | 57K | 1.67 | -5.11% | 70K |
| NERV | Minerva Neurosciences, Inc. | +7.31% | -28.13% | -41.69% | -62.88% | -43.37% | -41.25% | 8.7% | 9.0% | 1.80 | 9K | 2.35 | +1.29% | 17K |
| LFMD | Lifemd, Inc. | +10.84% | -16.06% | -41.03% | -54.81% | -60.38% | -32.55% | 5.7% | 5.2% | 0.67 | 53K | 2.30 | +0.00% | 36K |
| VYGR | Voyager Therapeutics, Inc. | +1.14% | -27.05% | -43.13% | -54.01% | -60.66% | -54.59% | 6.0% | 6.8% | 1.36 | 56K | 1.78 | +3.49% | 76K |
| NGEN | NERVGEN PHARMA CORP. | -4.96% | -24.29% | -19.76% | -63.19% | — | -77.21% | 7.1% | 5.5% | 0.74 | 29K | 1.34 | -2.19% | 21K |
| CRDL | Cardiol Therapeutics Inc. | -7.11% | -25.89% | -22.59% | -22.01% | -7.93% | +9.86% | 4.6% | 5.0% | 0.37 | 86K | 1.04 | -5.86% | 32K |
| MSLE | Satellos Bioscience Inc. | -0.39% | -23.22% | -34.43% | -16.85% | — | -44.74% | 3.5% | 4.7% | 0.03 | 1K | 6.46 | -4.22% | 40 |
| SEER | Seer, Inc. | -9.56% | -22.22% | -20.99% | -10.49% | -21.52% | -4.11% | 6.6% | 4.2% | 1.65 | 17K | 1.75 | +3.86% | 28K |
| NMRA | Neumora Therapeutics, Inc. | +25.68% | -0.44% | -69.11% | -78.51% | -83.07% | -72.39% | 14.9% | 12.6% | 1.97 | 88K | 0.49 | +34.69% | 172K |
| MIST | Milestone Pharmaceuticals Inc. | +12.66% | -9.51% | -37.79% | -61.49% | -61.29% | -64.06% | 7.0% | 6.3% | 0.34 | 52K | 0.73 | -1.65% | 18K |
| GNLX | GENELUX Corp | +5.26% | -21.57% | -29.08% | -29.95% | -74.75% | -54.08% | 8.2% | 7.2% | 0.50 | 17K | 2.00 | -4.31% | 8K |
| RLYB | Rallybio Corp | -4.66% | -5.99% | -3.28% | +84.77% | +256.66% | +189.04% | 2.1% | 1.0% | 2.45 | 500 | 15.77 | +0.64% | 1K |
| COYA | Coya Therapeutics, Inc. | -18.23% | -32.92% | -29.40% | -23.91% | -47.44% | -44.36% | 8.5% | 6.2% | 0.68 | 7K | 3.23 | -11.02% | 5K |
| MBOT | Microbot Medical Inc. | +10.40% | -9.96% | -43.17% | -50.48% | -52.07% | -48.00% | 7.2% | 5.6% | 0.99 | 27K | 1.04 | -4.59% | 26K |
| CGTX | COGNITION THERAPEUTICS INC | +2.11% | -23.75% | -29.34% | -44.40% | -57.46% | -47.50% | 5.6% | 6.3% | 0.09 | 17K | 0.71 | +1.15% | 2K |
| OPXS | Optex Systems Holdings Inc | -3.20% | -11.58% | -16.46% | -14.44% | -46.00% | -34.38% | 1.8% | 1.5% | 2.81 | 787 | 9.24 | +0.71% | 2K |
| QUCY | Quantum Cyber N.V. | -12.24% | -44.27% | -50.65% | +93.67% | — | +3.42% | 8.5% | 8.4% | 0.10 | 24K | 0.76 | -10.50% | 2K |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | +0.24% | -42.91% | -40.59% | -6.00% | +31.37% | +8.46% | 13.7% | 12.1% | 0.83 | 3K | 4.23 | -10.00% | 2K |
| XBIT | XBiotech Inc. | +3.30% | -14.35% | -15.70% | -26.13% | -23.58% | -20.00% | 4.1% | 3.2% | 1.99 | 1K | 1.88 | -2.59% | 2K |
| CTOR | CITIUS ONCOLOGY, INC. | +2.12% | -36.14% | -10.94% | -31.23% | -62.53% | -38.39% | 8.1% | 6.4% | 0.50 | 2K | 0.60 | +9.49% | 1K |
| OSTX | OS Therapies Inc | -4.96% | -29.45% | -29.66% | -30.72% | -34.66% | -17.56% | 6.3% | 7.3% | 1.43 | 22K | 1.15 | -5.74% | 32K |
| XLO | Xilio Therapeutics, Inc. | +4.49% | -12.26% | -13.57% | -0.51% | -32.10% | -13.74% | 4.2% | 4.0% | 0.40 | 600 | 7.80 | -4.18% | 239 |
| IBIO | iBio, Inc. | +12.70% | -29.08% | -45.73% | -49.67% | -48.86% | -59.09% | 6.0% | 7.5% | 0.14 | 32K | 0.80 | +4.81% | 5K |
| GANX | Gain Therapeutics, Inc. | -1.31% | -33.92% | -36.16% | -40.53% | -35.80% | -64.85% | 5.4% | 6.9% | 0.22 | 25K | 1.13 | -0.88% | 6K |
| KLRS | Kalaris Therapeutics, Inc. | +11.73% | -25.79% | -54.02% | -63.90% | -57.63% | -76.16% | 4.8% | 5.7% | 0.44 | 3K | 2.00 | -1.72% | 1K |
| IMA | ImageneBio, Inc. | +1.26% | -12.01% | -28.16% | -30.87% | -47.46% | -41.34% | 3.4% | 3.0% | 0.25 | 411 | 4.03 | -2.89% | 103 |
| TIL | Instil Bio, Inc. | +17.44% | -7.30% | -8.08% | -20.10% | -64.24% | -40.30% | 4.7% | 4.3% | 0.22 | 670 | 6.60 | -2.94% | 150 |
| PTHS | Pelthos Therapeutics Inc. | -26.40% | -45.78% | -57.75% | -54.50% | -65.49% | -62.47% | 28.9% | 10.8% | 6.36 | 2K | 11.38 | +9.59% | 11K |
| DWTX | Dogwood Therapeutics, Inc. | +9.95% | -18.46% | -33.24% | -15.62% | -80.85% | -70.79% | 5.9% | 5.8% | 0.30 | 2K | 1.22 | -6.18% | 547 |
| INMB | Inmune Bio, Inc. | -3.17% | -28.94% | -28.20% | -8.33% | -20.06% | -11.29% | 6.6% | 5.9% | 0.83 | 19K | 1.38 | -4.84% | 16K |
| NYXH | Nyxoah SA | +6.04% | -35.04% | -39.51% | -69.38% | -83.07% | -81.07% | 2.7% | 3.4% | 0.04 | 10K | 0.88 | +1.14% | 351 |
| EXOZ | EXOZYMES INC. | -1.48% | -36.00% | -53.65% | -60.69% | -63.17% | -62.26% | 3.7% | 6.9% | 0.58 | 204 | 4.00 | -2.20% | 118 |
| ALDX | Aldeyra Therapeutics, Inc. | -10.39% | -50.07% | -62.19% | -63.94% | -88.41% | -88.72% | 10.5% | 10.2% | 1.15 | 52K | 0.58 | +4.30% | 60K |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | -10.47% | -23.48% | -66.31% | -71.86% | -75.92% | -75.59% | 5.3% | 4.7% | 0.02 | 12K | 0.70 | -5.07% | 271 |
| PRPO | Precipio, Inc. | -9.81% | -23.65% | -21.49% | -39.30% | -6.12% | -24.46% | 4.8% | 4.0% | 0.11 | 8K | 17.79 | -2.36% | 821 |
| WOK | WORK Medical Technology Group LTD | -8.18% | -40.59% | -53.46% | — | — | — | 3.6% | 5.4% | 0.00 | 4K | 1.01 | -4.72% | 12 |
| MGX | Metagenomi Therapeutics, Inc. | -5.89% | -29.30% | -40.65% | -49.04% | -70.45% | -55.62% | 5.9% | 4.9% | 6.90 | 5K | 0.72 | -8.26% | 32K |
| CELU | Celularity Inc | +9.79% | -49.30% | +5.37% | -27.05% | -60.09% | -26.05% | 11.0% | 9.2% | 0.01 | 80K | 0.81 | +0.06% | 403 |
| NSPR | InspireMD, Inc. | +15.32% | -14.34% | -24.19% | -58.36% | -77.87% | -70.57% | 5.6% | 5.9% | 2.57 | 3K | 0.53 | +14.87% | 7K |
| DAIO | DATA I/O CORP | -8.91% | -21.67% | -23.70% | -8.38% | -28.79% | -26.10% | 3.9% | 2.1% | 0.18 | 1K | 2.35 | -1.67% | 182 |
| MIRA | MIRA PHARMACEUTICALS, INC. | +1.14% | -27.19% | -33.41% | -49.51% | -68.48% | -64.72% | 11.0% | 4.9% | 0.12 | 6K | 0.53 | -1.26% | 713 |
| ARAY | ACCURAY INC | +20.06% | -47.66% | -52.73% | -67.88% | -89.25% | -82.03% | 6.2% | 9.1% | 0.28 | 82K | 0.15 | +6.95% | 23K |
| LFWD | Lifeward Ltd. | +16.73% | — | — | -10.80% | -25.73% | -13.04% | 3.6% | 1.6% | 0.22 | 300 | 6.07 | +5.20% | 65 |
| CLIR | ClearSign Technologies Corp | +7.24% | -33.98% | -39.62% | -55.82% | -75.65% | -57.17% | 2.7% | 4.0% | 0.46 | 463 | 2.37 | +2.16% | 214 |
| ATYR | aTYR PHARMA INC | +4.66% | -44.23% | -69.42% | -81.23% | -82.21% | -79.44% | 17.6% | 10.8% | 1.95 | 3K | 6.38 | +29.15% | 5K |
| PIII | P3 Health Partners Inc. | +1.79% | -36.87% | -61.85% | +38.30% | -59.08% | +11.45% | 9.6% | 5.7% | 0.06 | 1K | 3.99 | -7.10% | 77 |
| LPCN | Lipocine Inc. | +0.00% | -30.43% | -30.94% | -38.46% | -49.30% | -82.40% | 3.7% | 10.0% | 0.11 | 54K | 1.44 | +0.00% | 6K |
| CLRB | Cellectar Biosciences, Inc. | -0.82% | -32.78% | -53.64% | -54.85% | -72.87% | -58.28% | 4.6% | 7.3% | 0.60 | 2K | 1.21 | +0.41% | 1K |
| TVRD | Tvardi Therapeutics, Inc. | -6.01% | -30.59% | -60.83% | -77.90% | -83.16% | -81.64% | 5.3% | 5.1% | 0.07 | 5K | 0.79 | -0.18% | 329 |
| PLSM | Pulsenmore Ltd. | -7.02% | -26.73% | -51.96% | -67.62% | — | -73.98% | 2.4% | 4.9% | 0.01 | 632 | 1.59 | -12.15% | 8 |
| PHIO | Phio Pharmaceuticals Corp. | +3.18% | -10.25% | -17.76% | -24.79% | -56.76% | -15.38% | 1.0% | 2.0% | 0.15 | 2K | 0.88 | +0.48% | 350 |
| INAB | IN8BIO, INC. | -7.54% | -26.03% | -12.58% | -35.46% | -53.32% | -58.91% | 4.6% | 4.1% | 0.11 | 1K | 0.96 | +6.83% | 113 |
| TOVX | Theriva Biologics, Inc. | +6.68% | -8.95% | -12.16% | -45.10% | -37.25% | -0.73% | 15.4% | 7.7% | 40.62 | 47K | 0.20 | +19.87% | 1.9M |
| PTN | PALATIN TECHNOLOGIES INC | +3.61% | -44.35% | -35.49% | -77.37% | — | -68.92% | 6.3% | 7.9% | 0.45 | 878 | 5.03 | -3.92% | 395 |
| LTRN | Lantern Pharma Inc. | +8.12% | -26.69% | -76.54% | -71.06% | -83.12% | -78.41% | 9.8% | 8.2% | 0.10 | 6K | 0.65 | +2.09% | 634 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | +12.81% | -19.63% | -46.74% | -79.21% | -81.57% | -79.94% | 3.2% | 6.5% | 0.01 | 7K | 0.90 | -3.91% | 100 |
Page of 2
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.